The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.
Open accessAbstract
Duchenne muscular dystrophy is a fatal disorder characterized by progressive muscular weakness, wasting, and severe muscle contractures in later disease stages. Muscle biopsy reveals conspicuous myofiber degeneration and fibrosis substituting muscle tissue. We quantitatively determined mRNA of the potent fibrogenic cytokine transforming growth factor-beta 1 by quantitative PCR in 15 Duchenne muscular dystrophy, 13 Becker muscular dystrophy, 11 spinal muscular atrophy patients, and 16 controls. Higher transforming growth factor-beta 1 expression was greater in Duchenne muscular dystrophy patients than controls (P = 0.012) and Becker patients (P = 0.03). Fibrosis was significantly more prominent in Duchenne muscular dystrophy than Becker muscular dystrophy, spinal muscular atrophy, and controls. The proportion of connective tissue in muscle biopsies increased progressively with age in Duchenne muscular dystrophy patients, while transforming growth factor-beta 1 levels peaked at 2 and 6 yr of age. Transforming growth factor-beta 1 protein was also detected by immunocytochemistry and immunoblotting. Our findings suggest that transforming growth factor-beta 1 stimulates fibrosis in Duchenne muscular dystrophy. Expression of transforming growth factor-beta 1 in the early stages of Duchenne muscular dystrophy may be critical in initiating muscle fibrosis and antifibrosis treatment could slow progression of the disease, increasing the utility of gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
Quantitation of mRNA by the polymerase chain reaction.
Wang, A. M., Doyle, M. V., & Mark, D. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9717 · Cited by 1,625
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Müller, C. R., Lindlöf, M., Kääriäinen, H. A., et al. (1989) · Europe PMC (PubMed Central) · Cited by 1,113
New Concepts about the Mast Cell
Flier, J. S., Underhill, L. H., & Galli, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280408 · Cited by 990
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346371a0 · Cited by 988
Broekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794
Transforming growth factor-beta: recent progress and new challenges.
Sporn, M. B., & Roberts, A. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.5.1017 · Cited by 769
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
Lyons, R. M., Gentry, L. E., Purchio, A. F., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1361 · Cited by 737
Transforming Growth Factors β1 and α in Chronic Liver Disease: Effects of Interferon Alfa Therapy
Castilla, A., Prieto, J., & Fausto, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241401 · Cited by 655
Arahata, K., & Engel, A. G. (1984) · Annals of Neurology · doi:10.1002/ana.410160206 · Cited by 630
Control of scarring in adult wounds by neutralising antibody to transforming growth factor β
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90009-r · Cited by 613
Fibrogenic cytokines: the role of immune mediators in the development of scar tissue
Kovacs, E. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90107-5 · Cited by 590
The TGF-β family and its composite receptors
Massagué, J., Attisano, L., & Wrana, J. L. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90202-x · Cited by 543
Siebert, P. D., & Larrick, J. W. (1992) · Nature · doi:10.1038/359557a0 · Cited by 530
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
Mendell, J. R., Moxley, R. T., Griggs, R. C., Brooke, M. H., Fenichel, G. M., Miller, J. P., King, W., Signore, L., Pandya, S., Florence, J., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202405 · Cited by 520
Transforming growth factor beta: the good, the bad, and the ugly.
Wahl, S. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1587 · Cited by 486
Inflammation: Basic Principles and Clinical Correlates
Fawthrop, F. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.10.701-b · Cited by 482
Inflammatory and immunomodulatory roles of TGF-β
Wahl, S. M., McCartney-Francis, N., & Mergenhagen, S. E. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90136-9 · Cited by 449
Giri, S. N., Hyde, D. M., & Hollinger, M. A. (1993) · Thorax · doi:10.1136/thx.48.10.959 · Cited by 402
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
Wolf, Y. G., Rasmussen, L. M., & Ruoslahti, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117070 · Cited by 304
Logan, A., Berry, M., Gonzalez, A. M., Frautschy, S. A., Sporn, M. B., & Baird, A. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00278.x · Cited by 297
Dasch, J. R., Pace, D. R., Waegell, W., Inenaga, D., & Ellingsworth, L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1536 · Cited by 293
5462925 Transforming growth factor beta2,3
(1996) · Biotechnology Advances · doi:10.1016/s0734-9750(97)81916-7 · Cited by 252
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals.
Brandes, M. E., Allen, J. B., Ogawa, Y., & Wahl, S. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115073 · Cited by 220
Quantitation of mRNA by the polymerase chain reaction
(1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2865-a · Cited by 185
Post-transcriptional regulation of the human transforming growth factor-beta 1 gene.
Kim, S. J., Park, K., Koeller, D., Kim, K. Y., Wakefield, L. M., Sporn, M. B., & Roberts, A. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42270-3 · Cited by 172
Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.
Wahl, S. M., Allen, J. B., Costa, G. L., Wong, H. L., & Dasch, J. R. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.1.225 · Cited by 155
Mantegazza, R., Andreetta, F., Bernasconi, P., Baggi, F., Oksenberg, J. R., Simoncini, O., Mora, M., Cornelio, F., & Steinman, L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116533 · Cited by 152
Self-citationMcDouall, R. M., Dunn, M. J., & Dubowitz, V. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90156-h · Cited by 147
A role for mast cells in the progression of Duchenne muscular dystrophy?
Gorospe, J. R. M., Tharp, M. D., Hinckley, J., Kornegay, J. N., & Hoffman, E. P. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90050-7 · Cited by 128
Yamazaki, M., Minota, S., Sakurai, H., Miyazono, K., Yamada, A., Kanazawa, I., & Kawai, M. (1994) · PubMed · Cited by 102
Transforming growth factor beta induces myoblast differentiation in the presence of mitogens.
Zentella‐Dehesa, A., & Massagué, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5176 · Cited by 95
New concepts about the mast cell
Galli, S. J. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90322-0 · Cited by 94
Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis
Gorospe, J. R. M., Tharp, M. D., Demitsu, T., & Hoffman, E. P. (1994) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)90068-x · Cited by 85
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy
D'Amore, P. A., Brown, R. H., Ku, P., Hoffman, E. P., Watanabe, H., Arahata, K., Ishihara, T., & Folkman, J. (1994) · Annals of Neurology · doi:10.1002/ana.410350320 · Cited by 84
Cyclosporine increases muscular force generation in Duhenne muscular dystrophy
Sharma, K. R., Mynhier, M. A., & Miller, R. G. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.527 · Cited by 75
Jullien, P., den Berg, T. M. B.-V., & Lawrence, D. A. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430525 · Cited by 74
Morandi, L. O., Mora, M., Gussoni, E., Tedeschi, S., & Cornelio, F. (1990) · Annals of Neurology · doi:10.1002/ana.410280512 · Cited by 42
Self-citationVery small dystrophin molecule in a family with a mild form of Becker dystrophy
Morandi, L. O., Mora, M., Bernasconi, P., Mantegazza, R., Gebbia, M., Balestrini, M. R., & Cornelio, F. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90043-j · Cited by 19
Self-citation
Cited by
Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle
Uezumi, A., Ito, T., Morikawa, D., Shimizu, N., Yoneda, T., Segawa, M., Yamaguchi, M., Ogawa, R., Matev, M. M., Miyagoe-Suzuki, Y., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.086629 · Cited by 680
“PDGFRa+ cells accumulate in fibrotic areas and express fibrosis-related molecules in the mdx diaphragm It is widely known that the mdx mouse, a mouse model of DMD, exhibits fibrosis in the diaphragm similar to that of DMD patients (Stedman et al., 1991).”
BackgroundInfluentialTransforming growth factor βs and wound healing
O'Kane, S., & Ferguson, M. W. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00120-3 · Cited by 634
Branton, M. H., & Kopp, J. B. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00250-6 · Cited by 603
MUSCLE INJURIES AND REPAIR: CURRENT TRENDS IN RESEARCH
HUARD, J., LI, Y., & FU, F. H. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200205000-00022 · Cited by 522
Li, Y., Foster, W., Deasy, B. M., Chan, Y., Prisk, V., Tang, Y., Cummins, J., & Huard, J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63188-4 · Cited by 451
Metadata
- Authors
- Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R., Barresi, R., Mora, M., Cornelio, F., Morandi, L., & Mantegazza, R.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-08-01
- Volume
- 96
- Issue
- 2
- Pages
- 1137-1144
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2097070825
- Cited by
- 297
- References
- 44
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.